Literature DB >> 23511951

Comparison of different blood sample processing methods for sensitive detection of low level chimerism by RHD real-time PCR assay.

Ahmad Javadi1, Esther P Verduin, Anneke Brand, Henk Schonewille.   

Abstract

The rhesus D blood group, which is expressed on the red blood cells (RBC) of 85% of the Caucasian population, is one of the most immunogenic RBC antigens, inducing D antibody formation in up to 20-80% of D-negative transfusion recipients and about 10% of pregnancies at risk. Pregnancy-induced D-antibodies can persist for many years, but the mechanisms underlying this persistence are unclear. The LOTUS study, a long-term follow-up study of mothers from severely affected children with hemolytic disease of the fetus and newborn investigates, among other endpoints, whether persistent feto-maternal chimerism is associated with long-term maternal anti-D persistence. We questioned which blood sample processing method should be used to detect low levels of RHD chimerism with the highest sensitivity and specificity using qPCR. After optimization of primer and probe concentrations for singleplex RHD exon 5 and 7 qPCR, sensitivity, specificity and efficiency of RHD and DYS1 qPCR were investigated in artificial chimeric samples. Sensitivity of DYS1 was one log higher (0.0001%) in enriched mononuclear cell fractions as compared with whole blood. Comparable linear sensitivity (0.007%) and mean efficiency (84-99%) for RHD qPCR were observed in all samples regardless whether whole blood or pre- or post-mixing of cellular fractions had been used. We conclude that RHD chimerism using singleplex exon 5 and 7 qPCR is linearly detectable down to 1.0 GE, without an advantage of fraction enrichment.

Entities:  

Keywords:  RHDchimerism; buffy coat; granulocytes; peripheral blood mononuclear cells; real-time PCR; whole blood

Mesh:

Substances:

Year:  2013        PMID: 23511951      PMCID: PMC3654739          DOI: 10.4161/chim.24248

Source DB:  PubMed          Journal:  Chimerism        ISSN: 1938-1964


  26 in total

1.  Detection of microchimerism by PCR is a function of amplification strategy.

Authors:  W F Reed; T L Lee; E Trachtenberg; M Vinson; M P Busch
Journal:  Transfusion       Date:  2001-01       Impact factor: 3.157

2.  Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma.

Authors:  Bernhard Zimmermann; Ahmad El-Sheikhah; Kypros Nicolaides; Wolfgang Holzgreve; Sinuhe Hahn
Journal:  Clin Chem       Date:  2005-07-14       Impact factor: 8.327

Review 3.  Competence and competition: the challenge of becoming a long-lived plasma cell.

Authors:  Andreas Radbruch; Gwendolin Muehlinghaus; Elke O Luger; Ayako Inamine; Kenneth G C Smith; Thomas Dörner; Falk Hiepe
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

4.  Epigenetic approaches for the detection of fetal DNA in maternal plasma.

Authors:  Dana Wy Tsui; Rossa Wk Chiu; Ym Dennis Lo
Journal:  Chimerism       Date:  2010 Jul-Sep

5.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Authors:  Y M Lo; M S Tein; T K Lau; C J Haines; T N Leung; P M Poon; J S Wainscoat; P J Johnson; A M Chang; N M Hjelm
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  Long persistence of rhesus antibodies.

Authors:  H E Hutchison; W McLennan
Journal:  Vox Sang       Date:  1966 Jul-Aug       Impact factor: 2.144

7.  Long-term follow-up testing of red cell alloantibodies.

Authors:  G Ramsey; S J Smietana
Journal:  Transfusion       Date:  1994-02       Impact factor: 3.157

8.  PCR-based methodology for molecular microchimerism detection and quantification.

Authors:  Josep-Maria Pujal; David Gallardo
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

9.  Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.

Authors:  Astrid G S van Halteren; Ewa Jankowska-Gan; Antoinette Joosten; Els Blokland; Jos Pool; Anneke Brand; William J Burlingham; Els Goulmy
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

10.  Clinical applications of cell-free fetal DNA from maternal plasma.

Authors:  Robbert J P Rijnders; Godelieve C M L Christiaens; Bernadette Bossers; Jasper J van der Smagt; C Ellen van der Schoot; Masja de Haas
Journal:  Obstet Gynecol       Date:  2004-01       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.